Edesa Biotech, Inc.·4

Jun 1, 5:00 PM ET

Nijhawan Pardeep 4

4 · Edesa Biotech, Inc. · Filed Jun 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Edesa Biotech (EDSA) CEO Pardeep Nijhawan Receives 1,671-Share Award

What Happened

  • Pardeep Nijhawan, CEO of Edesa Biotech (EDSA), was granted 1,671 restricted share units (RSUs) on 2026-06-01. The award was reported as an acquisition (code A) at $0.00 per share in a Form 4 filing and vested in full upon grant under the Issuer's 2019 Equity Incentive Compensation Plan.

Key Details

  • Transaction date: 2026-06-01; transaction type: Award/Grant (A).
  • Shares acquired: 1,671 RSUs; reported acquisition price/value: $0.00.
  • Filing date / Period of report: 2026-06-01 — filing appears timely (no late-filing flag).
  • Shares owned after the transaction: not specified in the filing.
  • Notable footnotes: (F1) RSUs vested in full upon grant per the 2019 Equity Incentive Compensation Plan; (F2 & F3) Nijhawan disclaims beneficial ownership of certain shares held by his wholly owned entities and as co-trustee of a family trust, except to the extent of his pecuniary interest.

Context

  • This was an equity award (not a market purchase or sale). Awards that vest immediately are compensation events rather than open-market purchases and do not by themselves indicate the insider is increasing or decreasing a market position.
  • The filing does not show any simultaneous sale or cashless exercise of these shares.

Insider Transaction Report

Form 4
Period: 2026-06-01
Nijhawan Pardeep
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Common Shares

    [F1]
    2026-06-01+1,671731,134 total
Holdings
  • Common Shares

    [F2]
    (indirect: Held by Pardeep Nijhawan Medicine Professional Corporation)
    402,702
  • Common Shares

    [F3]
    (indirect: By Trust)
    32,609
  • Common Shares

    [F2]
    (indirect: Held by The Digestive Health Clinic Inc.)
    32,013
  • Common Shares

    [F2]
    (indirect: Held by 1968160Ontario Inc.)
    53,104
Footnotes (3)
  • [F1]Reflects a grant of restricted share units, which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan.
  • [F2]Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Peter J. Weiler, Attorney-in-Fact for Pardeep Nijhawan|2026-06-01

Documents

1 file
  • 4
    ownership.xmlPrimary